Incyte News

Wells Fargo Maintains Incyte(INCY.US) With Hold Rating, Raises Target Price to $70

Futu NewsDec 21 02:40

Wells Fargo Adjusts Incyte's Price Target to $70 From $68, Keeps Equalweight Rating

MT NewswiresDec 19 22:39

Analysts Offer Insights on Healthcare Companies: Century Therapeutics (IPSC), Incyte (INCY) and Bicycle Therapeutics (BCYC)

TipRanksDec 18 13:41

Incyte Analyst Ratings

BenzingaDec 18 03:43

UBS Initiates Incyte(INCY.US) With Hold Rating, Announces Target Price $77

Futu NewsDec 17 23:32

JMP Securities Maintains Incyte(INCY.US) With Hold Rating

Futu NewsDec 17 13:32

Incyte's Mixed Clinical Results and Financial Challenges Lead to Hold Rating

TipRanksDec 17 13:31

Oppenheimer Maintains Incyte(INCY.US) With Buy Rating, Maintains Target Price $82

Futu NewsDec 14 05:31

Stifel Maintains Incyte(INCY.US) With Hold Rating, Maintains Target Price $75

Futu NewsDec 13 21:32

TD Cowen Maintains Incyte(INCY.US) With Buy Rating, Maintains Target Price $86

Futu NewsDec 13 20:31

BMO Capital Maintains Incyte(INCY.US) With Sell Rating, Maintains Target Price $52

Futu NewsDec 13 20:31

TD Cowen Reaffirms Their Buy Rating on Incyte (INCY)

TipRanksDec 13 20:28

Stifel Maintains Incyte(INCY.US) With Hold Rating, Maintains Target Price $75

Futu NewsDec 10 21:31

Stifel Nicolaus Sticks to Their Hold Rating for Incyte (INCY)

TipRanksDec 10 20:47

Analysts Offer Insights on Healthcare Companies: Keros Therapeutics (KROS), Incyte (INCY) and Prenetics Group (PRE)

TipRanksDec 6 00:04

RBC Capital Sticks to Its Hold Rating for Incyte (INCY)

TipRanksNov 28 09:49

TD Cowen Maintains Incyte(INCY.US) With Buy Rating, Raises Target Price to $86

Futu NewsNov 25 21:32

TD Cowen Remains a Buy on Incyte (INCY)

TipRanksNov 25 20:53

TD Cowen Adjusts Price Target on Incyte to $86 From $80, Keeps Buy Rating

MT NewswiresNov 25 19:48

Incyte Is Maintained at Sector Perform by RBC Capital

Dow JonesNov 19 23:52